Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05463016 · ClinicalTrials.gov registry record · NA
Impact of Color Correcting Lenses on Color Vision Deficiency
A NA study, sponsored by University of the Incarnate Word.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT05463016: Completed NA study, sponsored by University of the Incarnate Word.
NCT05463016 is a NA study that has completed, run by University of the Incarnate Word. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05463016, a NA study, has completed, sponsored by University of the Incarnate Word.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
To demonstrate improved color vision in subjects with color vision deficiencies while wearing color-correcting lenses and after color-correcting lense use.
Primary Outcome
Cone Contrast Sensitivity (CS) Test (CCT, Innova Systems, Inc.): red, green \& blue cone CS using 100-point scale based on log changes in CS. Values will be converted to Z-scores to compare to outcomes with other units.
Interventions
- DEVICE Experimental Group 1: Color Correcting Lenses
- DEVICE Placebo Group 1: Placebo Lenses
- DEVICE Placebo Group 1 Crosses over to become Experimental Group 2: Color Correcting Lenses
- DEVICE Experimental Group 1 Crosses over to become Placebo Group 2: Placebo Lenses
- DEVICE Color Correcting Lenses in Subjects with Normal Color Vision
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2022-07-28 |
| Est. Completion | 2024-03-31 |
| Phase | NA |
What the finished NCT05463016 record still lists
NCT05463016 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which Experimental Group 1: Color Correcting Lenses is the first listed.
NCT05463016 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05463016 about?
NCT05463016 is a clinical study titled "Impact of Color Correcting Lenses on Color Vision Deficiency". To demonstrate improved color vision in subjects with color vision deficiencies while wearing color-correcting lenses and after color-correcting lense use.
What is the current status of trial NCT05463016?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2022-07-28. Estimated completion is 2024-03-31.
What interventions are being tested in trial NCT05463016?
The interventions under investigation include: Experimental Group 1: Color Correcting Lenses (DEVICE), Placebo Group 1: Placebo Lenses (DEVICE), Placebo Group 1 Crosses over to become Experimental Group 2: Color Correcting Lenses (DEVICE), Experimental Group 1 Crosses over to become Placebo Group 2: Placebo Lenses (DEVICE), Color Correcting Lenses in Subjects with Normal Color Vision (DEVICE).
Who is sponsoring clinical trial NCT05463016?
This trial is sponsored by University of the Incarnate Word, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05463016's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI